{"ticker": {"uuid": "d2f7bbfa-9197-41c6-9085-6d778880b202", "symbol": "COV", "name": "Cleo Diagnostics Ltd", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Cleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOMTlUWVNPMGRqdGxSb2pPVGxtVUpSYndmYzZoQjFjU2NOTllmUW1rUmlqb190YWJZNHByQW1KY3hPbjRFMjJrWWkweXMwdk01Qkl1cU1GM0R6TThGTVhnTTFqX1c2NFVaX1hNcVgxaEdwdEdLaXA5dnd0WWRIWWE2YS1icnJNZVVxNG9iNnFPQTNsclFJaXdBVkUzM3VHUHVnQXNiaDlBT0V4bTMtMWRXaFZ1cFFGb2FsOG84SXBWRG1ZUWFXN2I0MEpUYUVIelRDa3lSVWdXTnYwbkp3?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:14:00+00:00", "published_display": "13 Jul 2026 07:14", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLEO Diagnostics (ASX:COV) Slips as ASX Biotech Volatility Stays in Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNV1NNd1E0Y3BCeW9INEhNSGthZng3clh4VllfeU13ckpYV3htOHNlT3NFM0liMnRnbjZGYndUNExFN0JmdE82cDhvOTRZX1hxakZ2NXVEMllTVmxoRXFYWWxtLV9yelBZdFliT3BhQWI4TGJSbW1kWVU4RnJ0T1RvMmR1NW9vcWNBaVFFMzYyZDgxa1NFSHVuMDJ6MF9GZEJYeFFtNFBJWHotdGs5UEE?oc=5", "source_name": "Kalkine", "published_at": "2026-07-10T13:15:00+00:00", "published_display": "10 Jul 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLEO Diagnostics Director Restructures Holding of Unlisted Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQSWc0dHVhMXd5U0lhN1g2S2hjTFdTb0dwNjZpQ2hGdHdKYzc0VmhLU0ItMlViS2Ffb0FFWlV0LWtfUnVQVDNuWUdoaDRVTDhISkJuTWVzYTJvbEJXbF9abS1JdnA4Xy1uMEgtdEh1dzRmNnZqQ3hTNy1iVzAwVmRmLXZrY0pVV3h0ZnBXU0I3WU4yUjc4NHlrajloRWJWRlplNU1CbEVPcGVGYWlGLXdPN2hsc2VvRUVBV2c?oc=5", "source_name": "TipRanks", "published_at": "2026-07-07T07:02:43+00:00", "published_display": "07 Jul 2026 07:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Has Cleo Diagnostics (ASX:COV) Gained Nearly 27% Over the Past Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOUGZxSVVDS2g3ZElrbkpISWJGazNwdENkTWYyWUdTMXFVdUhFQ0p5S3cyLURwQWJQM1I4VWlWZGxZamtrTWdqUWkxamJ4eV90OU5lZkhjUnNFY29CcUFYeFlkQnBPMWdMeThSQTFOS3lQWWFZb0NkR2NvbXRTVnhxcEZ1cFZKdDRBM3h1aFNXMUR0MzhuRVc2MXlRb1JXREh4aFB1S0kySkN3RUZy?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLEO Diagnostics (ASX:COV) Is Under Pressure. Here\u2019s a Possible Explanation", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPX3IzMGEtcmF1SjE0T2NVN2UzLTZwY0VaUHdHV2x5OV9HSXM3MHBwY2dpZml5Z096WEU2VVpXd1BvOUR4QXU5VTFlUUdLbmJiblpWcmpxTThranpFTzM1YkM3U2wta3NNQTF5bnd0bXAtLXNrQmlyNjlPQ2d0UXZWQTdNTFZ6WGVOZ2xVUlViR24takh6WElXUWxBUW1rMTJRN2JjckpHcHFYSE9NN3JFXw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Cleo Diagnostics (ASX:COV) Can Easily Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTUJKWFVhcnNYTmRHZjEzU3dpY09sQ1hNSUhjMTJrdW40N01sMlZwYWJVaVB2ak1pb2hTSlVkdUNjQ24xb3d0ZWQ1eFdwS0xqYVRaSDM1Z1dhOU1veUFBTzducm9hSjJJaXMtTmxaekJGOG10bk9TMzBib0w5T1kyQTZPeTVNSm9CWU9VVWtKWjVMR1pDOFd1eXZEVQ?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like Cleo Diagnostics (ASX:COV) Are In A Position To Invest In Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-10T07:00:00+00:00", "published_display": "10 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cleo Diagnostics Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTFBEbUxTcXk3eEYyaXRKM2dUVngyMDZkbkh3Yl9YdGdfOFdUdlFPYjNJY1FvZFJRNlZKdXB4Qng3MGVNN2N4cE54NFhFbW8xTENpR2pieGhYb3FIbW9KeTZUYlJNbHJremxwQ3c?oc=5", "source_name": "Investing News Network", "published_at": "2023-11-16T16:55:23+00:00", "published_display": "16 Nov 2023 16:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cleo Diagnostics Ltd (ASX:COV) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1rMUJpb1JEN1AzdmhMT0NOeENPeklfS29DQmZ0WUxaamlvUUNaal9PcnItN3ZPS2RtdWVwenU1aGd2QnBjdEZ5Qzd5X0haaEZya0tQcUh0X1F4a3V4S1BlcVloN0NOZU5VWU1pb0RoMk1IVHhidEp2U2RFRkhjUlE?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-10-28T11:31:03+00:00", "published_display": "28 Oct 2023 11:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cleo Diagnostics Ltd (ASX: COV) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOVFpFTGc2Q2tIRUZPMmU3RTJTUDdFQ3o3YnY5Sk81ZS13WGFHTTlNcHcwUGlDNTNmZi1ETGVoUmhfRUlyd0ROcU12ZVZta1Y1V0xXVF84RGozRTZPelF5ZXhIdUlmTkRRaHczcFdnZ2lzSDEtWjRfS0FzMnhWVjR2dUNIdEJWcEM5NDJzYlM3OA?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-08-25T20:37:04+00:00", "published_display": "25 Aug 2023 20:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of CLEO Diagnostics Ltd (ASX:COV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9zalJTS29BazNHZ0s4WW5yRnZVVDVXUWMzd0g4MUpSN2hGMk5HNTFrbDVkMUpINGNQU2RreENOQVQwTEZOYlZPa1o5cXdSWnVtdjIwQk9PdnF1VkRwTFZYc0pZYUs5UQ?oc=5", "source_name": "TradingView", "published_at": "2023-08-16T04:52:23+00:00", "published_display": "16 Aug 2023 04:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COV Stock Price and Chart \u2014 ASX:COV", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1xVlg1Y0RpZE5CY2J1UVZBd3k3dmdjdks4Q1JIcXNuazBwLWxrRExqZlJtMTBXX28zajhTOFROUktocFN0SWFLLU96NHByc1VfbkhJYUV4QQ?oc=5", "source_name": "TradingView", "published_at": "2023-08-16T04:51:10+00:00", "published_display": "16 Aug 2023 04:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOMTlUWVNPMGRqdGxSb2pPVGxtVUpSYndmYzZoQjFjU2NOTllmUW1rUmlqb190YWJZNHByQW1KY3hPbjRFMjJrWWkweXMwdk01Qkl1cU1GM0R6TThGTVhnTTFqX1c2NFVaX1hNcVgxaEdwdEdLaXA5dnd0WWRIWWE2YS1icnJNZVVxNG9iNnFPQTNsclFJaXdBVkUzM3VHUHVnQXNiaDlBT0V4bTMtMWRXaFZ1cFFGb2FsOG84SXBWRG1ZUWFXN2I0MEpUYUVIelRDa3lSVWdXTnYwbkp3?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:14:00+00:00", "published_display": "13 Jul 2026 07:14", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLEO Diagnostics (ASX:COV) Slips as ASX Biotech Volatility Stays in Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNV1NNd1E0Y3BCeW9INEhNSGthZng3clh4VllfeU13ckpYV3htOHNlT3NFM0liMnRnbjZGYndUNExFN0JmdE82cDhvOTRZX1hxakZ2NXVEMllTVmxoRXFYWWxtLV9yelBZdFliT3BhQWI4TGJSbW1kWVU4RnJ0T1RvMmR1NW9vcWNBaVFFMzYyZDgxa1NFSHVuMDJ6MF9GZEJYeFFtNFBJWHotdGs5UEE?oc=5", "source_name": "Kalkine", "published_at": "2026-07-10T13:15:00+00:00", "published_display": "10 Jul 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLEO Diagnostics Director Restructures Holding of Unlisted Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQSWc0dHVhMXd5U0lhN1g2S2hjTFdTb0dwNjZpQ2hGdHdKYzc0VmhLU0ItMlViS2Ffb0FFWlV0LWtfUnVQVDNuWUdoaDRVTDhISkJuTWVzYTJvbEJXbF9abS1JdnA4Xy1uMEgtdEh1dzRmNnZqQ3hTNy1iVzAwVmRmLXZrY0pVV3h0ZnBXU0I3WU4yUjc4NHlrajloRWJWRlplNU1CbEVPcGVGYWlGLXdPN2hsc2VvRUVBV2c?oc=5", "source_name": "TipRanks", "published_at": "2026-07-07T07:02:43+00:00", "published_display": "07 Jul 2026 07:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Has Cleo Diagnostics (ASX:COV) Gained Nearly 27% Over the Past Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOUGZxSVVDS2g3ZElrbkpISWJGazNwdENkTWYyWUdTMXFVdUhFQ0p5S3cyLURwQWJQM1I4VWlWZGxZamtrTWdqUWkxamJ4eV90OU5lZkhjUnNFY29CcUFYeFlkQnBPMWdMeThSQTFOS3lQWWFZb0NkR2NvbXRTVnhxcEZ1cFZKdDRBM3h1aFNXMUR0MzhuRVc2MXlRb1JXREh4aFB1S0kySkN3RUZy?oc=5", "source_name": "Kalkine", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLEO Diagnostics (ASX:COV) Is Under Pressure. Here\u2019s a Possible Explanation", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPX3IzMGEtcmF1SjE0T2NVN2UzLTZwY0VaUHdHV2x5OV9HSXM3MHBwY2dpZml5Z096WEU2VVpXd1BvOUR4QXU5VTFlUUdLbmJiblpWcmpxTThranpFTzM1YkM3U2wta3NNQTF5bnd0bXAtLXNrQmlyNjlPQ2d0UXZWQTdNTFZ6WGVOZ2xVUlViR24takh6WElXUWxBUW1rMTJRN2JjckpHcHFYSE9NN3JFXw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Cleo Diagnostics (ASX:COV) Can Easily Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTUJKWFVhcnNYTmRHZjEzU3dpY09sQ1hNSUhjMTJrdW40N01sMlZwYWJVaVB2ak1pb2hTSlVkdUNjQ24xb3d0ZWQ1eFdwS0xqYVRaSDM1Z1dhOU1veUFBTzducm9hSjJJaXMtTmxaekJGOG10bk9TMzBib0w5T1kyQTZPeTVNSm9CWU9VVWtKWjVMR1pDOFd1eXZEVQ?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like Cleo Diagnostics (ASX:COV) Are In A Position To Invest In Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-10T07:00:00+00:00", "published_display": "10 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cleo Diagnostics Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTFBEbUxTcXk3eEYyaXRKM2dUVngyMDZkbkh3Yl9YdGdfOFdUdlFPYjNJY1FvZFJRNlZKdXB4Qng3MGVNN2N4cE54NFhFbW8xTENpR2pieGhYb3FIbW9KeTZUYlJNbHJremxwQ3c?oc=5", "source_name": "Investing News Network", "published_at": "2023-11-16T16:55:23+00:00", "published_display": "16 Nov 2023 16:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cleo Diagnostics Ltd (ASX:COV) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1rMUJpb1JEN1AzdmhMT0NOeENPeklfS29DQmZ0WUxaamlvUUNaal9PcnItN3ZPS2RtdWVwenU1aGd2QnBjdEZ5Qzd5X0haaEZya0tQcUh0X1F4a3V4S1BlcVloN0NOZU5VWU1pb0RoMk1IVHhidEp2U2RFRkhjUlE?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-10-28T11:31:03+00:00", "published_display": "28 Oct 2023 11:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cleo Diagnostics Ltd (ASX: COV) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOVFpFTGc2Q2tIRUZPMmU3RTJTUDdFQ3o3YnY5Sk81ZS13WGFHTTlNcHcwUGlDNTNmZi1ETGVoUmhfRUlyd0ROcU12ZVZta1Y1V0xXVF84RGozRTZPelF5ZXhIdUlmTkRRaHczcFdnZ2lzSDEtWjRfS0FzMnhWVjR2dUNIdEJWcEM5NDJzYlM3OA?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-08-25T20:37:04+00:00", "published_display": "25 Aug 2023 20:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of CLEO Diagnostics Ltd (ASX:COV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9zalJTS29BazNHZ0s4WW5yRnZVVDVXUWMzd0g4MUpSN2hGMk5HNTFrbDVkMUpINGNQU2RreENOQVQwTEZOYlZPa1o5cXdSWnVtdjIwQk9PdnF1VkRwTFZYc0pZYUs5UQ?oc=5", "source_name": "TradingView", "published_at": "2023-08-16T04:52:23+00:00", "published_display": "16 Aug 2023 04:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COV Stock Price and Chart \u2014 ASX:COV", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1xVlg1Y0RpZE5CY2J1UVZBd3k3dmdjdks4Q1JIcXNuazBwLWxrRExqZlJtMTBXX28zajhTOFROUktocFN0SWFLLU96NHByc1VfbkhJYUV4QQ?oc=5", "source_name": "TradingView", "published_at": "2023-08-16T04:51:10+00:00", "published_display": "16 Aug 2023 04:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 13, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 10, "score": 48, "total": 13, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.51, "latest_week": "2026-07-10", "one_week_move": 2.0, "four_week_move": 0.0, "twelve_week_move": -15.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.607688, "market_dynamics_buy_signal": false, "relative_strength": -3.185225, "fair_value_gap": 35.6, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 45.3243, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.0% over one week, +0.0% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 4}, {"label": "Market source", "count": 2}, {"label": "intelligentinvestor.com.au", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "TipRanks", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Investing News Network", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.0% over one week, +0.0% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Cleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist?"}], "updated_at": "2026-07-17T02:39:47.419032+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}